0001179110-20-010368.txt : 20201009 0001179110-20-010368.hdr.sgml : 20201009 20201009160427 ACCESSION NUMBER: 0001179110-20-010368 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201007 FILED AS OF DATE: 20201009 DATE AS OF CHANGE: 20201009 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Goldberg Mark Alan CENTRAL INDEX KEY: 0001532475 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37359 FILM NUMBER: 201233234 MAIL ADDRESS: STREET 1: 128 SPRING STREET, SUITE 520 CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Blueprint Medicines Corp CENTRAL INDEX KEY: 0001597264 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 45 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-374-7580 MAIL ADDRESS: STREET 1: 45 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml FORM 4 - X0306 4 2020-10-07 0 0001597264 Blueprint Medicines Corp BPMC 0001532475 Goldberg Mark Alan C/O BLUEPRINT MEDICINES CORPORATION 45 SIDNEY STREET CAMBRIDGE MA 02139 1 0 0 0 Common Stock 2020-10-07 4 M 0 5454 19.53 A 9016 D Common Stock 2020-10-07 4 S 0 5454 100 D 3562 D Stock Option (Right to Buy) 19.53 2020-10-07 4 M 0 5454 0 D 2026-06-23 Common Stock 5454 5455 D Effected pursuant to a trading plan adopted on August 5, 2020 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. This option was granted on June 23, 2016 and is fully vested as of the date hereof. /s/ Ariel Hurley, Attorney-in-Fact 2020-10-09